These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 28321605)

  • 41. Mechanism of action of methylphenidate: insights from PET imaging studies.
    Volkow ND; Fowler JS; Wang G; Ding Y; Gatley SJ
    J Atten Disord; 2002; 6 Suppl 1():S31-43. PubMed ID: 12685517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EEG Brain Wave Activity at Rest and during Evoked Attention in Children with Attention-Deficit/Hyperactivity Disorder and Effects of Methylphenidate.
    Thomas BL; Viljoen M
    Neuropsychobiology; 2016; 73(1):16-22. PubMed ID: 26812442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The rCBF brain mapping in adolescent ADHD comorbid developmental coordination disorder and its changes after MPH challenging.
    Yeh CB; Huang WS; Lo MC; Chang CJ; Ma KH; Shyu JF
    Eur J Paediatr Neurol; 2012 Nov; 16(6):613-8. PubMed ID: 22417719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects.
    Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E
    Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study.
    O'Gorman RL; Mehta MA; Asherson P; Zelaya FO; Brookes KJ; Toone BK; Alsop DC; Williams SC
    Neuroimage; 2008 Aug; 42(1):36-41. PubMed ID: 18511306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Misuse of Methylphenidate.
    Clemow DB
    Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Seasonal Patterns of Medications for Treating Attention-Deficit/Hyperactivity Disorder: Comparison of Methylphenidate and Atomoxetine.
    Shyu YC; Lee SY; Yuan SS; Yang CJ; Yang KC; Lee TL; Wang LJ
    Clin Ther; 2016 Mar; 38(3):595-602. PubMed ID: 26874787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.
    Langleben DD; Acton PD; Austin G; Elman I; Krikorian G; Monterosso JR; Portnoy O; Ridlehuber HW; Strauss HW
    J Nucl Med; 2002 Dec; 43(12):1624-9. PubMed ID: 12468511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest-posttest study.
    Akay AP; Resmi H; Güney SA; Erkuran HÖ; Özyurt G; Sargin E; Topuzoglu A; Tufan AE
    Eur Child Adolesc Psychiatry; 2018 Jan; 27(1):127-135. PubMed ID: 28710695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder: Three-Year Naturalistic Follow-Up of a 52-Week Methylphenidate Trial.
    Ginsberg Y; Långström N; Larsson H; Lindefors N
    J Clin Psychopharmacol; 2015 Oct; 35(5):535-43. PubMed ID: 26284932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stimulant Treatment Trajectories Are Associated With Neural Reward Processing in Attention-Deficit/Hyperactivity Disorder.
    Schweren LJS; Groenman A; von Rhein D; Weeda W; Faraone SF; Luman M; van Ewijk H; Heslenfeld DJ; Franke B; Buitelaar JK; Oosterlaan J; Hoekstra PJ; Hartman CA
    J Clin Psychiatry; 2017 Jul; 78(7):e790-e796. PubMed ID: 28640989
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects.
    Hart H; Radua J; Nakao T; Mataix-Cols D; Rubia K
    JAMA Psychiatry; 2013 Feb; 70(2):185-98. PubMed ID: 23247506
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.
    Ginsberg Y; Lindefors N
    Br J Psychiatry; 2012 Jan; 200(1):68-73. PubMed ID: 22075648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD).
    Retz W; Retz-Junginger P
    Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S35-43. PubMed ID: 25231833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
    Rhodes SM; Coghill DR; Matthews K
    J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
    Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
    Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. First-Dose Methylphenidate-Induced Changes in Brain Functional Connectivity Are Correlated With 3-Month Attention-Deficit/Hyperactivity Disorder Symptom Response.
    Silberstein RB; Levy F; Pipingas A; Farrow M
    Biol Psychiatry; 2017 Nov; 82(9):679-686. PubMed ID: 28465019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.